Eli Lilly & Co(CH:LLY)
CHF 1,220.00+20.00 (+1.67%)
CH:LLY
Eli Lilly & Co earnings date
CHF 1,220.00
At close:+20.00 (+1.67%)
Eli Lilly & Co (LLY) Q2 2024 Earnings Report
4 Followers
CH:LLY Q2 2024 EPS Results
- Actual EPS
- CHF 3.29
- Consensus EPS
- CHF 2.30
- Beat/Miss
- Beat by +CHF 0.99
- One Year Ago EPS
- CHF 1.77
CH:LLY Q2 2024 Revenue Results
- Actual Revenue
- CHF 9.48B
- Expected Revenue
- CHF 8.38B
- Beat/Miss
- Beat by +CHF 1.11B
- YoY Revenue Growth
- +35.98%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- Before Open
- Conference Call
- Thursday, August 8, 2024
CH:LLY Upcoming Earnings
Eli Lilly & Co's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:LLY Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:LLY Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | 9.41- | 6.33 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 4.796.28 | 5.89 | 6.55% (+0.39) | |
| Aug 05, 2026 | 2026 (Q2) | 5.377.03 | 5.29 | 32.81% (+1.74) | |
| Apr 30, 2026 | 2026 (Q1) | 5.857.17 | 2.8 | 155.99% (+4.37) | |
| Feb 04, 2026 | 2025 (Q4) | 5.806.33 | 4.46 | 41.73% (+1.86) | |
| Oct 30, 2025 | 2025 (Q3) | 4.785.89 | 0.99 | 494.92% (+4.90) | |
| Aug 07, 2025 | 2025 (Q2) | 4.705.29 | 3.29 | 60.97% (+2.01) | |
| May 01, 2025 | 2025 (Q1) | 2.732.80 | 2.16 | 29.46% (+0.64) | |
| Feb 06, 2025 | 2024 (Q4) | 4.234.46 | 2.09 | 113.65% (+2.37) | |
| Oct 30, 2024 | 2024 (Q3) | 1.190.99 | 0.08 | 1080.00% (+0.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


